Portola Pharmaceuticals Inc.® (Nasdaq: PTLA) today announced that on August 3, 2017 it resubmitted its Biologics License Application (BLA) to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE